Vascular Malformation: Clinical Trials

3 trials for Vascular Malformation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 withdrawn. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Withdrawn 1

Follow Vascular Malformation: new trials by email Literature Review of Vascular Malformation trials Research Report on Vascular Malformation

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Enalapril in Treatment of Venous Malformations
Enalapril - Venous Malformation, Pain
Phase 2RecruitingOslo University Hospital122025-02-012025-04-02
suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS
Sirolimus - Vascular Malformation
Phase 2CompletedUniversity Hospital, Tours632015-09-302025-12-22
Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding
Thalidomide, Placebo - Gastrointestinal Hemorrhage, Vascular Malformation
Phase 2WithdrawnShanghai Jiao Tong University School of Medicine2010-03-012016-04-28

Narrower conditions

Vascular Malformations (3)  ·  Angiodysplasia (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Pain (1)

Broader conditions

Cardiovascular Abnormalities (3)  ·  Cardiovascular Diseases (3)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Digestive System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Hemorrhage (1)  ·  Neurologic Manifestations (1)  ·  Pathologic Processes (1)  ·  Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Enalapril (1)  ·  Sirolimus (1)  ·  Thalidomide (1)

Sponsors

Oslo University Hospital (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  University Hospital, Tours (1)

Countries

China (1)  ·  France (1)  ·  Norway (1)

Top investigators

Annabel Maruani, MD, PhD (1)  ·  Zhizheng Ge, Ph.D, MD. (1)

Results publications

PMID 29945674, PMID 34524406

NIH funding

2015 (1), 2023 (1)